In the last decade, transcatheter aortic valve implantation (TAVI) has shown to be a feasible and effective therapeutic alternative in patients with symptomatic severe aortic stenosis (AS) and contraindications or high risk for surgical aortic valve replacement.1–3 Several studies have shown excellent, sustained transvalvular haemodynamics post-TAVI, together with a significant improvement in symptoms and quality of life.4–6 However, the impact of TAVI on left ventricular (LV) systolic and...
